Hintonia latiflora has been clinically researched for over 60 years because its bark extract yields a number of valuable compounds that reduce high blood sugar levels.

This six-month clinical study included 41 volunteers who has symptoms of diabetes for at least 12 months and elevated fasting blood glucose levels in the 7 to 14 mmol/l range. (For comparison, the normal value is from 3.9 to 5.4 mmol/l). The participants ranged in age from 45 to 80 years, with the average being about 60 years old. While the individuals in the study were already following a dietary regimen for diabetes that stabilized their blood sugar numbers, it wasn’t enough to bring those numbers into the normal range. Nonetheless, their diets didn’t change during the study – the researchers wanted to see the impact of Hintonia without adding other factors to the mix.

Hintonia did quite well. As it was shown in other clinical research, the botanical lowered A1C levels significantly. It also reduced fasting glucose by 25 percent and postprandial glucose by 22 percent.

But importantly, blood sugar levels never dropped to be too low, either. So people who have struggled with blood sugar levels throughout the day – with either spikes or slumps – could use this clinically studied Hintonia without worry. Additionally, Hintonia normalized cholesterol and triglyceride numbers as well – making it an excellent choice for anyone struggling with metabolic syndrome, the clustering of diabetes, cholesterol, and other cardiovascular conditions.

Abstract:

Korecova M, Hladikova M. Treatment of mild and moderate type-2 diabetes: open prospective trial with Hintonia latiflora extract. Eur J Med Res. 2014 Mar 28;19:16.

Background: Extracts from the bark of Hintonia latiflora are used as dietetic measures to support the regulation of glucose metabolism and the stabilization of blood glucose values.

Methods: A dry concentrated extract from the bark of Hintonia latiflora in capsule form was tested in an open, prospective clinical study in 41 dietetically stabilized subjects with type 2 diabetes. The effects on parameters of blood glucose control were documented over a period of six months.

Results: Fasting and postprandial glucose and the HbA1c value declined significantly. In the case of HbA1c, this meant a reduction of the absolute value from 7.49 ± 0.72% to 6.82 ± 0.67% (from 58.4 to 51.0 mmol/mol Hb; intention to treat (ITT) population). Furthermore, cholesterol and triglycerides were slightly reduced and no negative effect on other laboratory parameters and no change of the liver values were observed. Tolerance was very good. In particular, no side effects and no hypoglycemic episodes or worsening of diabetic symptoms occurred.

Conclusions: The study confirms the positive effect of extracts from the bark of Hintonia latiflora on blood glucose values suggesting a potential benefit in the management of glucose metabolism in cases of type 2 diabetes.

Link to the complete study: Treatment of mild and moderate type-2 diabetes: open prospective trial with Hintonia latiflora extract